Payment overview · 2025
General Payments
$111.49
1 reported records · 1 companies
Healthcare provider profile · identity verified
Taylor Sula, DNP
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner · WEST DES MOINES, IA · NPI 1518445766
Verified facts
What the public records show
CMS Open Payments records show Taylor Sula, DNP received $111.49 in general payments during 2025 across 1 reported records.
Teva Pharmaceuticals USA, Inc. accounted for 100.0% of that reported general-payment amount.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $111.49 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Education | $111.49 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
Payment records were found, but the reported records did not identify a specific associated product for this analysis.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Sertraline Hcl | Sertraline Hcl | 465 | 69 |
| Lorazepam | Lorazepam | 404 | 80 |
| Memantine Hcl | Memantine Hcl | 349 | 50 |
| Trazodone Hcl | Trazodone Hcl | 330 | 63 |
| Tramadol Hcl | Tramadol Hcl | 321 | 48 |
| Levothyroxine Sodium | Levothyroxine Sodium | 320 | 56 |
| Furosemide | Furosemide | 319 | 78 |
| Amlodipine Besylate | Amlodipine Besylate | 299 | 58 |
| Donepezil Hcl | Donepezil Hcl | 281 | 46 |
| Gabapentin | Gabapentin | 246 | 46 |
| Atorvastatin Calcium | Atorvastatin Calcium | 241 | 48 |
| Losartan Potassium | Losartan Potassium | 227 | 38 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 226 | 42 |
| Lisinopril | Lisinopril | 216 | 42 |
| Metoprolol Succinate | Metoprolol Succinate | 181 | 30 |
| Omeprazole | Omeprazole | 174 | 41 |
| Potassium Chloride | Potassium Chloride | 168 | 42 |
| Pantoprazole Sodium | Pantoprazole Sodium | 164 | 30 |
| Mirtazapine | Mirtazapine | 156 | 29 |
| Oxycodone Hcl | Oxycodone Hcl | 151 | 32 |
| Eliquis | Apixaban | 144 | 23 |
| Tamsulosin Hcl | Tamsulosin Hcl | 136 | 25 |
| Metoprolol Tartrate | Metoprolol Tartrate | 128 | 25 |
| Escitalopram Oxalate | Escitalopram Oxalate | 126 | 26 |
| Quetiapine Fumarate | Quetiapine Fumarate | 126 | 27 |
| Clonazepam | Clonazepam | 97 | 17 |
| Duloxetine Hcl | Duloxetine Hcl | 96 | 20 |
| Famotidine | Famotidine | 87 | 14 |
| Buspirone Hcl | Buspirone Hcl | 84 | 20 |
| Warfarin Sodium | Warfarin Sodium | 83 | suppressed |
| Fentanyl | Fentanyl | 82 | suppressed |
| Metformin Hcl | Metformin Hcl | 81 | 16 |
| Spironolactone | Spironolactone | 78 | 15 |
| Midodrine Hcl | Midodrine Hcl | 75 | 15 |
| Jardiance | Empagliflozin | 69 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 67 | 18 |
| Prednisone | Prednisone | 67 | 38 |
| Pravastatin Sodium | Pravastatin Sodium | 65 | suppressed |
| Olanzapine | Olanzapine | 63 | 11 |
| Fluoxetine Hcl | Fluoxetine Hcl | 61 | suppressed |
| Nyamyc | Nystatin | 58 | 34 |
| Hydralazine Hcl | Hydralazine Hcl | 56 | 11 |
| Januvia | Sitagliptin Phosphate | 56 | suppressed |
| Risperidone | Risperidone | 56 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 54 | 19 |
| Bumetanide | Bumetanide | 50 | suppressed |
| Carvedilol | Carvedilol | 49 | suppressed |
| Levetiracetam | Levetiracetam | 48 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 48 | suppressed |
| Ozempic | Semaglutide | 45 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 44 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 44 | 26 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 43 | 31 |
| Gemtesa | Vibegron | 41 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 41 | suppressed |
| Cephalexin | Cephalexin | 40 | 26 |
| Citalopram Hbr | Citalopram Hydrobromide | 40 | suppressed |
| Alprazolam | Alprazolam | 39 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 39 | 11 |
| Myrbetriq | Mirabegron | 38 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 37 | 26 |
| Fluticasone Propionate | Fluticasone Propionate | 37 | 19 |
| Simvastatin | Simvastatin | 37 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 35 | suppressed |
| Allopurinol | Allopurinol | 34 | suppressed |
| Phenobarbital | Phenobarbital | 34 | suppressed |
| Topiramate | Topiramate | 34 | suppressed |
| Lacosamide | Lacosamide | 33 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 30 | suppressed |
| Pregabalin | Pregabalin | 29 | suppressed |
| Aripiprazole | Aripiprazole | 28 | suppressed |
| Enulose | Lactulose | 28 | suppressed |
| Baclofen | Baclofen | 27 | suppressed |
| Nystatin | Nystatin | 27 | 18 |
| Amiodarone Hcl | Amiodarone Hcl | 26 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 25 | suppressed |
| Lactulose | Lactulose | 25 | 11 |
| Nystop | Nystatin | 25 | 19 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 24 | 15 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 23 | 20 |
| Atenolol | Atenolol | 23 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 23 | suppressed |
| Lamotrigine | Lamotrigine | 22 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 22 | suppressed |
| Cefdinir | Cefdinir | 21 | 15 |
| Clonidine Hcl | Clonidine Hcl | 21 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 21 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 21 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 21 | suppressed |
| Carbamazepine Er | Carbamazepine | 20 | suppressed |
| Haloperidol | Haloperidol | 20 | suppressed |
| Clozapine | Clozapine | 19 | suppressed |
| Dotti | Estradiol | 19 | suppressed |
| Lorazepam Intensol | Lorazepam | 19 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 18 | suppressed |
| Celecoxib | Celecoxib | 18 | suppressed |
| Finasteride | Finasteride | 18 | suppressed |
| Novolog Flexpen | Insulin Aspart | 18 | suppressed |
| Insulin Lispro | Insulin Lispro | 17 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 17 | 15 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 17 | suppressed |
| Azithromycin | Azithromycin | 16 | 12 |
| Calcitriol | Calcitriol | 16 | suppressed |
| Latanoprost | Latanoprost | 16 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 16 | suppressed |
| Meloxicam | Meloxicam | 15 | suppressed |
| Tradjenta | Linagliptin | 15 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 15 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 14 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 14 | 12 |
| Glimepiride | Glimepiride | 14 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 14 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Bupropion Xl | Bupropion Hcl | 13 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 13 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 13 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 13 | 13 |
| Venlafaxine Hcl | Venlafaxine Hcl | 13 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 12 | suppressed |
| Dulera | Mometasone/Formoterol | 12 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 12 | suppressed |
| Ketoconazole | Ketoconazole | 12 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 12 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 12 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 12 | suppressed |
| Vilazodone Hcl | Vilazodone Hcl | 12 | suppressed |
| Xarelto | Rivaroxaban | 12 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 11 | suppressed |
| Dexamethasone | Dexamethasone | 11 | suppressed |
| Glipizide | Glipizide | 11 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 11 | suppressed |
| Hydroxyurea | Hydroxyurea | 11 | suppressed |
| Levofloxacin | Levofloxacin | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $111.49 · 1 records | Teva Pharmaceuticals USA, Inc. | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error